All stock lists
Inter & Co. Inc. (NASDAQ:INTR)
BR · Delayed Price · Currency is USD
Financial Services · Banks - Regional
4.43-0.25 (-5.34%)
Market cap
$1.96B
Insider Score
Health Score
Analyst consensus
Listed since
Jun 23, 2022
Website
Insider Score
––Not scored
INTR Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Weak
From INTR’s reported statements · Q2 2026 (trailing 12 months)
Profitability15 / 20
Profitable, but on a thin margin.
- Revenue
- $16.71B
- Net income
- $1.54B
- Net margin
- 9.2%
Leverage0 / 20
Heavily indebted for what it earns.
- Total debt
- $32.60B
- Cash
- $10.40B
- Net debt / EBITDA
- 9.72x
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $10.40B
- Current liabilities
- $31.14B
- Current ratio
- 0.33
Cash generation2 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$2.57B
- Free cash flow
- -$2.65B
- FCF margin
- -15.9%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 441.5M
- Share growth (1y)
- 0.4%
- Cash runway
- 49 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
INTR Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 4.58 B | 4.19 B | 4.12 B | 3.82 B | 3.43 B | 3.02 B |
| Revenue Growth (YoY) | 33.74 % | 38.97 % | 47.84 % | 51.92 % | 52.23 % | 39.46 % |
| Cost of Revenue | 2.72 B | 2.53 B | 2.41 B | 2.29 B | 1.99 B | 1.72 B |
| Gross Profit | 1.87 B | 1.66 B | 1.71 B | 1.52 B | 1.43 B | 1.30 B |
| SG&A Expense | 332.35 M | 883.22 M | 887.66 M | 815.17 M | 780.76 M | 751.31 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.34 B | 1.18 B | 1.24 B | 1.10 B | 1.05 B | 939.14 M |
| Operating Income | 522.40 M | 477.12 M | 465.19 M | 417.93 M | 383.53 M | 357.55 M |
| Pretax Income | 522.40 M | 477.12 M | 465.19 M | 417.93 M | 383.53 M | 357.55 M |
| Tax Provision | 66.60 M | 59.57 M | 62.83 M | 61.92 M | 51.36 M | 50.76 M |
| Net Income | 430.66 M | 394.79 M | 374.39 M | 336.35 M | 315.13 M | 286.59 M |
| EPS (Basic) | 0.98 | 0.88 | 0.88 | 0.75 | 0.72 | 0.65 |
| EPS (Diluted) | 0.98 | 0.88 | 0.88 | 0.75 | 0.71 | 0.65 |
| Shares Outstanding | 441.46 M | 441.35 M | 441.32 M | 448.46 M | 439.78 M | 439.89 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.